Justin M. Balko
机构: Professor of Medicine, and Pathology, Microbiology, and Immunology, Vanderbilt University
每年引用次数
引用次数
引用: 25,299
H-指数: 69
I10-指数 : 124
出版物: 332
A microRNA gene expression signature predicts response to erlotinib in epithelial cancer cell lines and targets EMT.
J L Bryant , J Britson , J M Balko , M Willian
British Journal of Cancer 106 ( 1) 148 -156
106
2012
P-REX1 creates a positive feedback loop to activate growth factor receptor, PI3K/AKT and MEK/ERK signaling in breast cancer
L M Dillon , J R Bean , W Yang , K Shee
Oncogene 34 ( 30) 3968 -3976
46
2015
Targeting EphA2 impairs cell cycle progression and growth of basal-like/triple-negative breast cancers
W Song , Y Hwang , V M Youngblood , R S Cook
Oncogene 36 ( 40) 5620 -5630
82
2017
Novel mechanism in cardiac injury: immune checkpoints
E.M Screever , M.L Axelrod , M.A Blair , D.Z Trykall
European Heart Journal 41
1
2020
Rationale for targeting the Ras/MAPK pathway in triple-negative breast cancer.
Jennifer M Giltnane , Justin M Balko
Discovery Medicine 17 ( 95) 275 -283
166
2014
Triple-Negative Breast Cancer: Breast Tumors With an Identity Crisis.
Ingrid A Mayer , Justin M Balko , Sara E Nunnery
Cancer Journal 27 ( 1) 2 -7
2021
Abstract PD9-06: Peripheral blood gene signatures predict response to neoadjuvant chemotherapy in breast cancer patients
Sara M Tolaney , Melinda E. Sanders , Ingrid A Mayer , Ian E Krop
Cancer Research
2021
Abstract PS4-19: Evaluation of tumor-specific MHC-II expression as a biomarker
Melinda Sanders , Justin M Balko , Violeta Sanchez , Paula Ines Gonzalez Ericsson
Cancer Research 81
2021
Progesterone promotes immunomodulation and tumor development in the murine mammary gland.
Zachary C Hartman , Alfredo A Molinolo , Mary A Markiewicz , Prabhakar Chalise
Journal for ImmunoTherapy of Cancer 9 ( 5)
2021
Abstract GS3-08: Multiplatform analysis of matched primary and metastatic breast tumors from the AURORA US Network
Tari A King , Minetta C Liu , Marni B McClure , Toshinori Hinoue
Cancer Research 80
1
2020
Abstract P3-08-15: Immunologic correlates of long-term outcome in the residual disease of triple-negative breast cancer after neoadjuvant chemotherapy
Justin M Balko , Mellissa Nixon , Paula I Gonzalez-Ericsson , Mark A Pilkinton
Cancer Research 80
2020
MEK and EGFR inhibition demonstrate synergistic activity in EGFR-dependent NSCLC.
Justin M Balko , Brett R Jones , Virginia L Coakley , Esther P Black
Cancer Biology & Therapy 8 ( 6) 522 -530
26
2009
A Genetic Mouse Model Recapitulates Immune Checkpoint Inhibitor–Associated Myocarditis and Supports a Mechanism-Based Therapeutic Intervention
Spencer C Wei , Wouter C Meijers , Margaret L Axelrod , Nana-Ama A.S. Anang
Cancer Discovery 11 ( 3) 614 -625
96
2021
Profiling of residual breast cancers after neoadjuvant chemotherapy identifies DUSP4 deficiency as a mechanism of drug resistance
Justin M Balko , Rebecca S Cook , David B Vaught , María G Kuba
Nature Medicine 18 ( 7) 1052 -1059
165
2012
Cardiovascular toxicities associated with immune checkpoint inhibitors: an observational, retrospective, pharmacovigilance study.
Joe-Elie Salem , Ali Manouchehri , Melissa Moey , Bénédicte Lebrun-Vignes
Lancet Oncology 19 ( 12) 1579 -1589
245
2018
Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research.
Douglas B Johnson , Kerry L Reynolds , Ryan J Sullivan , Justin M Balko
Lancet Oncology 21 ( 8)
66
2020
A gene expression predictor of response to EGFR-targeted therapy stratifies progression-free survival to cetuximab in KRAS wild-type metastatic colorectal cancer
Justin M Balko , Esther P Black
BMC Cancer 9 ( 1) 145 -145
29
2009
The genomic map of breast cancer: which roads lead to better targeted therapies?
Justin M Balko , Thomas P Stricker , Carlos L Arteaga
Breast Cancer Research 15 ( 4) 209 -209
9
2013
Abstract P3-04-03: PIK3CA mutations in androgen receptor-positive triple negative breast cancer confer sensitivity to the combination of PI3K and androgen receptor inhibitors
Brian D Lehmann , Joshua A Bauer , Johanna M Schafer , Christopher S Pendleton
Cancer Research 75
2015
Abstract P6-03-03: Enrichment of janus kinase-2 (JAK2)-amplified tumor cell populations in triple-negative breast cancers (TNBC) during chemotherapy treatment
Luis J Schwarz , Justin M Balko , Jennifer M Giltnane , Monica V Estrada
Cancer Research 75
2015